Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sachse

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
American Journal of Human Genetics|February 1, 1997
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequencesC Sachse, J Brockmöller, S Bauer, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeineC Sachse, J Brockmöller, S Bauer, et al.
Pharmacogenetics|April 20, 1999
Detection of the GSTM1*0 allele by long polymerase chain reactionR Kerb, J Brockmöller, C Sachse, et al.
Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V|November 1, 1996
[Expression of various monoclonal antibodies in nodules and band stage in Dupuytren's disease]P Brenner, C Sachse, B Reichert, et al.
European Journal of Haematology|March 13, 2003
Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessmentC Sachse, M H Groschup, R Warzok, et al.
Pharmacogenetics|February 18, 1999
Correctness of prediction of the CYP2D6 phenotype confirmed by genotyping 47 intermediate and poor metabolizers of debrisoquineC Sachse, J Brockmöller, M Hildebrand, et al.
Toxicology Letters|February 18, 1999
Polymorphisms in xenobiotic conjugation and disease predispositionJ Brockmöller, I Cascorbi, R Kerb, et al.
Physiology International|July 16, 2019
Sex differences in cardiovascular responses to orthostatic challenge in healthy older persons: A pilot studyC Sachse, I Trozic, B Brix, et al.
Clinical Chemistry and Laboratory Medicine|June 3, 1999
Association between reduced human leukocyte antigen (HLA)-DR expression on blood monocytes and increased plasma level of interleukin-10 in patients with severe burnsC Sachse, M Prigge, G Cramer, et al.
Pharmacogenetics|June 1, 1996
A rare insertion of T226 in exon 1 of CYP2D6 causes a frameshift and is associated with the poor metabolizer phenotype: CYP2D6*15C Sachse, J Brockmöller, S Bauer, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Human Genetics|February 1, 1997
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequencesC Sachse, J Brockmöller, S Bauer, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeineC Sachse, J Brockmöller, S Bauer, et al.
Pharmacogenetics|April 20, 1999
Detection of the GSTM1*0 allele by long polymerase chain reactionR Kerb, J Brockmöller, C Sachse, et al.
Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V|November 1, 1996
[Expression of various monoclonal antibodies in nodules and band stage in Dupuytren's disease]P Brenner, C Sachse, B Reichert, et al.
European Journal of Haematology|March 13, 2003
Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessmentC Sachse, M H Groschup, R Warzok, et al.
Pharmacogenetics|February 18, 1999
Correctness of prediction of the CYP2D6 phenotype confirmed by genotyping 47 intermediate and poor metabolizers of debrisoquineC Sachse, J Brockmöller, M Hildebrand, et al.
Toxicology Letters|February 18, 1999
Polymorphisms in xenobiotic conjugation and disease predispositionJ Brockmöller, I Cascorbi, R Kerb, et al.
Physiology International|July 16, 2019
Sex differences in cardiovascular responses to orthostatic challenge in healthy older persons: A pilot studyC Sachse, I Trozic, B Brix, et al.
Clinical Chemistry and Laboratory Medicine|June 3, 1999
Association between reduced human leukocyte antigen (HLA)-DR expression on blood monocytes and increased plasma level of interleukin-10 in patients with severe burnsC Sachse, M Prigge, G Cramer, et al.
Pharmacogenetics|June 1, 1996
A rare insertion of T226 in exon 1 of CYP2D6 causes a frameshift and is associated with the poor metabolizer phenotype: CYP2D6*15C Sachse, J Brockmöller, S Bauer, et al.
Pageof 5